BLACK DIAMOND THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.78
-4.30%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-5.3%
3 months
+2.6%
6 months
-31.5%
1 year
-53.4%
Year to date
-26.8%
52-week range
$1.61 – $4.87
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$102.3M
P/E
-2.4
P/B
1.1
P/S
—
Revenue
$0
Net income
-$42.56M
Diluted EPS
-0.74
Gross margin
—
Net margin
—
Return on equity
-38.80%
Total debt
$13.1M
Cash
$20.03M
Free cash flow
-$32.83M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$9.91M | — | — | -$7.97M |
| Mar 31, 2026 | $0 | -$9.04M | — | — | -$10.23M |
| Dec 31, 2025 | $0 | -$15.12M | — | — | -$6.78M |
| Sep 30, 2025 | $0 | -$8.5M | — | — | -$7.85M |
| Jun 30, 2025 | $0 | -$10.56M | — | — | -$9.15M |
| Mar 31, 2025 | $70M | $56.54M | 100.00% | 80.80% | $53.42M |
| Dec 31, 2024 | $0 | -$15.99M | — | — | -$15.05M |
| Sep 30, 2024 | $0 | -$15.56M | — | — | -$11.28M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent BDTX news
All market newsNo ticker-linked stories are in the current archive.